Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • We guide you
    • Fertility
    • Healthy Pregnancy
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
    • Patients
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
  • Kit Request
  • About us
    • Igenomix Research
    • About Igenomix
  • Academy
  • Webinars
  • Blog
  • +1 (905) 565-9495 Request Information
  • French
Genetic Solutions > CGT

CGT: Carrier Genetic Test

Determines the risk of having a child with a genetic disease

  • Technical Overview
  • Documentation
  • Scientific evidence
  • I’m not a health specialist

Inherited disorders represent 20% of the causes of infant mortality in developed countries.

Sensitivity of 98%

Different CGT options available: CGT 600, CGT 250 and CGT one

Test results in 20 working days.

Are you interested?

Request information Or Email us at infocanada@igenomix.com
Overview
  • CGT
  • Benefits
  • Indications

What is CGT?

CGT is an advanced carrier genetic test, which determines whether a couple are carriers of genetic mutations that could be transmitted to their children.

CGT uses Next-Generation Sequencing (NGS) to analyse a wide panel of disorders including as Cystic Fibrosis, Spinal Muscular Atrophy, Fragile-X Syndrome.

What CGT test options are available?

CGT 600

Uses NGS to analyse 6,600 pathogenic mutations across 547 genes linked to more than 600 genetic disorders. It is the most complete panel currently available.

CGT 250

Uses NGS to analyse 3,500 pathogenic mutations across 250 genes mutations associated with the most prevalent diseases.

CGT ONE

Recommended in cases where the person has a family history and believes they carry a mutation in a specific gene. CGT One uses NGS to sequence the entire gene or a panel of genes linked to the disease in order to locate the existing mutations.

Who should use CGT test?

  • Couples who plan on forming a family and want to know the risk of transmitting hereditary disorders to their children
  • Patients planning an assisted reproduction treatment
  • Patients planning a treatment with donor sperm or eggs

Most carriers of genetic mutations don’t have a family history of these disorders.

Why use CGT test?

Is a clinically validated genetic screening test based on Next-Generation Sequencing (NGS).
Our different CGT options, tailored to each patient’s needs, make it the most complete test available.

See the full list of diseases

Test limitations

  • The sensitivity of the test is 98%.
  • We only analyze genes on the list available at www.cgt.igenomix.com, reporting results based on knowledge current at the time of testing. Therefore, only genes included in this list will be detected.
  • The sensitivity of the test is 98%.
  • The method is based on analysis by massive parallel sequencing and bioinformatics, studying all the exons of the genes included on our gene list. This includes adjacent intronic regions before or after position +5 and -5. Variants located outside the gene regions studied, such as gene-expression regulatory regions or intronic regions before or after position +5 and -5 are not detected.
  • No inversions, deletions, or duplications over 20 nucleotides long that are not referred to in the list available at www.cgt.igenomix.com are studied.
  • Germ mosaics (mutations only present in gametes) are not detected by this analysis because the DNA material studied is obtained from a blood sample.
  • A negative result for the genes indicated does not exclude the possibility that a de novo mutation may appear in the offspring.
Documentation
  • CGT Specialists' documents

French Clinical Sheets

Download

English Clinical Sheets

Download

English Brochure

Download

French Brochure

Download
Scientific evidence

Relevant related studies:

If you´re a little lost with this technical information...

Can we help you?

I’m not a health specialist

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility doctors worldwide we investigate human reproduction to change the lives of couples who are trying to conceive.

Other services you may be interested

PGT-M

Prevents the transmission of single gene disorders

More information

Oncodona

Risk detection of hereditary breast and ovarian cancer

More information

PGS + ERA Synchrony

The best embryo at the right time

More information

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

OUR SERVICES

Genetic solutions
Learn about genetics

ABOUT US

About Igenomix
Contact
Press and news
Quality
Work with us

FOLLOW IGENOMIX

Blog: Road to fertility

*CAP accreditation applies to the LA lab.

  +1 (905) 565-9495  fax +1 (905) 671-1938
  Email us
  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
Language

[2019] © Igenomix Privacy policy Quality policy Terms & conditions User Feedback

Request Information


  • reCAPTCHA demo: Simple page

  • We guide you
    • Fertility
    • Healthy Pregnancy
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
    • Patients
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
  • Kit Request
  • About us
    • Igenomix Research
    • About Igenomix
  • Academy
  • Webinars
  • Blog
  • French
  • Canada